• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关死亡:德国两波疫情间死亡率数据的对比分析。

COVID-19-related deaths: a 2-year inter-wave comparison of mortality data from Germany.

机构信息

Regensburg Department of Public Health, Altmühlstr. 3, 93059, Regensburg, Germany.

Department of Epidemiology and Preventive Medicine, Faculty of Medicine, University of Regensburg, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

出版信息

Infection. 2023 Aug;51(4):1147-1152. doi: 10.1007/s15010-023-01982-4. Epub 2023 Jan 24.

DOI:10.1007/s15010-023-01982-4
PMID:36690889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9870770/
Abstract

PURPOSE

The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has caused substantial mortality worldwide. We investigated clinical and demographic features of COVID-19-related deaths that occurred between March 2020 and January 2022 in Regensburg, Germany.

METHODS

We compared data across four consecutive time periods: March 2020 to September 2020 (period 1), October 2020 to February 2021 (period 2), March 2021 to August 2021 (period 3), and September 2021 to January 2022 (period 4).

RESULTS

Overall, 405 deaths in relation to COVID-19 were reported. The raw case fatality ratio (CFR) was 0.92. In periods 1 to 4, the CFRs were 1.70%, 2.67%, 1.06%, and 0.36%. The age-specific CFR and mortality were highest in persons aged ≥ 80 years in period 2 while mortality in younger cases increased with time. The median age at death was 84 years and it varied slightly across periods. Around 50% of cases of death were previously hospitalized. In all time periods, the cause of death was mostly attributed to COVID-19. Over the four periods, we did not find significant changes in the distribution of sex and risk factors for severe disease. The most frequent risk factor was cardio-circulatory disease.

CONCLUSION

In conclusion, the CFR decreased over time, most prominently for period 4. Mortality was considerable and younger cases were increasingly at risk.

摘要

目的

严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)在全球范围内造成了大量死亡。我们调查了 2020 年 3 月至 2022 年 1 月期间在德国雷根斯堡发生的与 COVID-19 相关的死亡的临床和人口统计学特征。

方法

我们比较了四个连续时间段的数据:2020 年 3 月至 2020 年 9 月(第 1 期)、2020 年 10 月至 2021 年 2 月(第 2 期)、2021 年 3 月至 2021 年 8 月(第 3 期)和 2021 年 9 月至 2022 年 1 月(第 4 期)。

结果

总体而言,报告了与 COVID-19 相关的 405 例死亡。原始病死率(CFR)为 0.92。在第 1 至 4 期,CFR 分别为 1.70%、2.67%、1.06%和 0.36%。第 2 期年龄特异性 CFR 和死亡率在≥80 岁人群中最高,而年轻病例的死亡率随时间增加。死亡的中位年龄为 84 岁,各期略有差异。约 50%的死亡病例之前曾住院治疗。在所有时间段,死亡的主要原因均归因于 COVID-19。在四个时期,我们没有发现性别和严重疾病风险因素的分布有显著变化。最常见的危险因素是心血管疾病。

结论

总之,CFR 随时间降低,尤其是第 4 期。死亡率相当高,年轻病例的风险越来越大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07d/9870770/8c85f7d290a2/15010_2023_1982_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07d/9870770/8c85f7d290a2/15010_2023_1982_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a07d/9870770/8c85f7d290a2/15010_2023_1982_Fig1_HTML.jpg

相似文献

1
COVID-19-related deaths: a 2-year inter-wave comparison of mortality data from Germany.COVID-19 相关死亡:德国两波疫情间死亡率数据的对比分析。
Infection. 2023 Aug;51(4):1147-1152. doi: 10.1007/s15010-023-01982-4. Epub 2023 Jan 24.
2
COVID or not COVID: attributing and reporting cause of death in a community cohort.新冠还是非新冠:社区队列中死亡原因的归因和报告。
Public Health. 2022 Apr;205:157-163. doi: 10.1016/j.puhe.2022.02.008. Epub 2022 Mar 11.
3
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.癌症患者 COVID-19 死亡率的时间依赖性:OnCovid 登记处的最新分析。
JAMA Oncol. 2022 Jan 1;8(1):114-122. doi: 10.1001/jamaoncol.2021.6199.
4
Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases.德国雷根斯堡的 COVID-19 的临床和流行病学数据:1084 例连续病例的回顾性分析。
Infection. 2021 Aug;49(4):661-669. doi: 10.1007/s15010-021-01580-2. Epub 2021 Mar 5.
5
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy).来自米兰(意大利伦巴第大区)一个单中心队列的新型冠状病毒肺炎(SARS-CoV-2)感染住院患者全因死亡率趋势。
Z Gesundh Wiss. 2022;30(8):1985-1993. doi: 10.1007/s10389-021-01675-y. Epub 2022 Jan 4.
6
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.在 2020 年春季大流行期间估计 SARS-CoV-2 在纽约市的感染病死率:基于模型的分析。
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.
7
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
8
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.2020 年 2 月至 2021 年 3 月期间美国种族和农村地区与 SARS-CoV-2 感染、死亡率和病死率关联变化的研究:一项基于人群的队列研究。
PLoS Med. 2021 Oct 21;18(10):e1003807. doi: 10.1371/journal.pmed.1003807. eCollection 2021 Oct.
9
Excess all-cause mortality during COVID-19 outbreak: potential role of untreated cardiovascular disease.新冠疫情期间全因死亡率过高:未治疗心血管疾病的潜在作用。
Minerva Cardiol Angiol. 2022 Apr;70(2):160-166. doi: 10.23736/S2724-5683.20.05349-9. Epub 2020 Sep 30.
10
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.新型冠状病毒病(COVID-19)大流行对侵袭性肺炎球菌病的影响以及与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)发生肺炎球菌合并感染的风险:英格兰全国前瞻性队列研究。
Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. doi: 10.1093/cid/ciaa1728.

引用本文的文献

1
Clinical outcomes in kidney transplant recipients receiving tixagevimab/cilgavimab for outpatient treatment of COVID-19: a single-center retrospective study.接受替沙格韦单抗/西加韦单抗门诊治疗新冠肺炎的肾移植受者的临床结局:一项单中心回顾性研究
Front Transplant. 2025 Jun 10;4:1579226. doi: 10.3389/frtra.2025.1579226. eCollection 2025.
2
Internet-based cognitive behavioral therapy for psychological symptoms during the final phase of the COVID-19 pandemic: a feasibility study.新冠疫情最后阶段基于互联网的心理症状认知行为疗法:一项可行性研究
Front Digit Health. 2025 Jun 9;7:1504217. doi: 10.3389/fdgth.2025.1504217. eCollection 2025.
3

本文引用的文献

1
Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic.大流行第一年丹麦与 COVID-19 相关的残疾调整生命年。
BMC Public Health. 2022 Jul 9;22(1):1315. doi: 10.1186/s12889-022-13694-9.
2
Lockdown Due to COVID-19 and Its Consequences on Diet, Physical Activity, Lifestyle, and Other Aspects of Daily Life Worldwide: A Narrative Review.由于 COVID-19 而实施的封锁及其对全球饮食、身体活动、生活方式和日常生活其他方面的影响:一项叙述性综述。
Int J Environ Res Public Health. 2022 Jun 2;19(11):6832. doi: 10.3390/ijerph19116832.
3
Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains.
Impact of the COVID-19 pandemic on admissions of deceased to an institute of legal medicine in Germany.
新冠疫情对德国一所法医学机构接收死者入院情况的影响。
Sci Rep. 2025 Apr 29;15(1):15115. doi: 10.1038/s41598-025-97117-w.
4
Persistent mortality in critical COVID-19 ICU cases from wild-type to delta variant: A descriptive cohort study.重症新型冠状病毒肺炎(COVID-19)重症监护病房(ICU)病例从野生型到德尔塔变异株的持续死亡率:一项描述性队列研究。
Sci Rep. 2025 Mar 25;15(1):10191. doi: 10.1038/s41598-025-94483-3.
5
Epidemiological characterization of COVID-19 in children under 18 years old in Mexico: an analysis of the pandemic.墨西哥18岁以下儿童新冠病毒病的流行病学特征:一项大流行分析
Front Pediatr. 2025 Jan 7;12:1440107. doi: 10.3389/fped.2024.1440107. eCollection 2024.
6
The spatial-temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022.COVID-19 病死率的时空变化及其影响因素:2021 年 2 月至 2022 年 5 月 30 个国家的全球研究。
Epidemiol Infect. 2024 Oct 17;152:e124. doi: 10.1017/S0950268824000852.
7
A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity.用于评估冠状病毒 Nsp5/3CLpro 活性的海肾荧光素酶报告基因检测法。
Sci Rep. 2024 Sep 5;14(1):20697. doi: 10.1038/s41598-024-71305-6.
8
SARS-CoV-2 infections in patients, health care workers and hospital outbreaks during the first 3 waves of the pandemic: a retrospective analysis in a secondary care hospital network in Germany.SARS-CoV-2 感染患者、医护人员和医院疫情在大流行的前 3 波:德国二级保健医院网络中的回顾性分析。
BMC Infect Dis. 2024 Aug 26;24(1):859. doi: 10.1186/s12879-024-09641-1.
9
Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study.一项前瞻性观察性队列研究中COVID-19住院患者与非COVID-19社区获得性肺炎住院患者临床结局的比较。
Infection. 2024 Dec;52(6):2359-2370. doi: 10.1007/s15010-024-02292-z. Epub 2024 May 18.
10
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care?在 COVID-19 大流行的四个波次中,住院患者特征的演变以及死亡的预测因素:它们是否是影响患者护理的移动目标?
Front Public Health. 2024 Jan 8;11:1280835. doi: 10.3389/fpubh.2023.1280835. eCollection 2023.
严重急性呼吸系统综合征冠状病毒 2 变种关注:新兴更具传染性和疫苗抗性菌株的视角。
Viruses. 2022 Apr 16;14(4):827. doi: 10.3390/v14040827.
4
COVID or not COVID: attributing and reporting cause of death in a community cohort.新冠还是非新冠:社区队列中死亡原因的归因和报告。
Public Health. 2022 Apr;205:157-163. doi: 10.1016/j.puhe.2022.02.008. Epub 2022 Mar 11.
5
The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.各国病例年龄分布对 COVID-19 病死率的贡献:九国人口研究。
Ann Intern Med. 2020 Nov 3;173(9):714-720. doi: 10.7326/M20-2973. Epub 2020 Jul 22.